HOME > TOP STORIES
TOP STORIES
-
REGULATORY Council on “Clinical Innovation Network” Holds 1st Meeting, 7 Working Groups to Design Registries
August 21, 2015
-
REGULATORY MHLW to Seek FY2016 Budgets for Genomic Data Collection, Registry-Based Trial Platform
August 20, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Full Interview with FPMAJ’s Kamoya - Part 1
August 20, 2015
-
BUSINESS Rheumatism Specialty Firm Ayumi Eyes Sales of 40-60 Billion Yen in 10 Years
August 19, 2015
-
BUSINESS Sawai’s Evista Generic Approved after Patent Battle
August 18, 2015
-
ORGANIZATION Govt Leadership Needed to Promote Industry Reorganization, Strengthen Competitiveness: Former JPMA President Aoki
August 17, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 7: Patient Group Hails Dawn of New Cancer Treatment Era
August 14, 2015
-
ORGANIZATION Govt’s Policy Blueprint Will Lead to Soaring R&D Costs, More Early-Stage Projects: JPMA Drug Evaluation Chief
August 14, 2015
-
BUSINESS Kyowa Kirin Looks to Derive 40% of Sales Overseas by 2020, Split from Holdings Firm Won’t Happen: Pres.
August 13, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Full Interview with JPA Executive Director Abe
August 13, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 6: CAR T-Cell Therapy Another Hot Field in Immuno-Oncology
August 12, 2015
-
TRENDS Japan Drug Makers See Rising Overseas Sales Ratios in April-June
August 11, 2015
-
ORGANIZATION Drug Pricing Tomorrow: FPMAJ’s Kamoya Says Innovation Premium Meant to Head Off Future Drug Lags
August 10, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 5: Merck & Co. Discovers New Biomarkers for Keytruda
August 7, 2015
-
BUSINESS 80% Generic Target “Completely Unexpected,” and Makes Stable Growth in Japan Market Difficult: Pfizer Pres.
August 6, 2015
-
ORGANIZATION JPMA IP Committee Chair Predicts “Minimum Standard” for Data Protection Period for Drugs
August 5, 2015
-
BUSINESS Kyowa Kirin to Draw Up 5-Year Midterm Plan Focusing on Development of Global Products: President Hanai
August 4, 2015
-
ORGANIZATION “All-Japan” System Needed to Contend with Top Global Drug Makers: JPMA R&D Head
August 3, 2015
-
BUSINESS Wholesalers Must Ponder Use of Reps for New Business: Mediceo CEO
July 31, 2015
-
BUSINESS AbbVie Pres. Says Japan Attracting Foreign Investments, Confident in Hep C Drug
July 31, 2015
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
